A Cancer Patient's Peptide Mimics a Binding Site in Interleukin-11
Author Information
Author(s): Marina Cardó-Vila, Amado J. Zurita, Ricardo J. Giordano, Jessica Sun, Roberto Rangel, Liliana Guzman-Rojas, Cristiane D. Anobom, Ana P. Valente, Fábio C. L. Almeida, Johanna Lahdenranta, Mikhail G. Kolonin, Wadih Arap, Renata Pasqualini
Primary Institution: The University of Texas M. D. Anderson Cancer Center
Hypothesis
The peptide motif isolated from a cancer patient functions as a new binding site within IL-11.
Conclusion
The peptide CGRRAGGSC mimics a receptor-binding site in IL-11 and induces cell proliferation through STAT3 activation.
Supporting Evidence
- The peptide CGRRAGGSC specifically binds to IL-11Rα.
- Binding of CGRRAGGSC to IL-11Rα is inhibited by recombinant IL-11.
- Mutations in key residues of the peptide significantly reduce binding to IL-11Rα.
- CGRRAGGSC induces cell proliferation in IL-11Rα-expressing cells.
- STAT3 activation is observed upon binding of CGRRAGGSC to IL-11Rα.
Takeaway
Scientists found a tiny piece of protein from a cancer patient that acts like a key to unlock a door in the body, helping cells grow.
Methodology
The study used binding assays, site-directed mutagenesis, and NMR spectroscopy to analyze the interaction between the peptide and IL-11Rα.
Limitations
The study faced challenges with protein misfolding and steric hindrance during mutational analysis.
Participant Demographics
The peptide was isolated from a cancer patient.
Statistical Information
P-Value
p<0.005
Statistical Significance
p<0.005
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website